Top Markets
Coin of the day
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Peringkat dalam Saham #38791
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Harga Saham
$0.099
Kapitalisasi Pasar
$801.50K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-34.44%
Negara
US
Perdagangan ZyVersa Therapeutics, Inc. (ZVSA)

Kategori

Riwayat hasil dividen untuk ZyVersa Therapeutics, Inc. (ZVSA)
Hasil dividen (TTM) dari ZyVersa Therapeutics, Inc. (simbol saham: ZVSA) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk ZyVersa Therapeutics, Inc. (ZVSA) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing